BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Science in Vancouver - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Science in Vancouver
X-ORIGINAL-URL:https://scienceinvancouver.com
X-WR-CALDESC:Events for Science in Vancouver
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20190310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20191103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200421T130000
DTEND;TZID=America/Vancouver:20200421T140000
DTSTAMP:20260409T002838
CREATED:20200415T154430Z
LAST-MODIFIED:20200415T154430Z
UID:11080-1587474000-1587477600@scienceinvancouver.com
SUMMARY:How to Navigate Fast Track Approval during COVID-19
DESCRIPTION:During these times of uncertainty\, LifeSciences BC hopes to offer support in any way it can. This webinar is free for everyone.\n\n\n\n\n\n\nAbout this Event\n\n\nDuring these times of uncertainty\, LifeSciences BC hopes to offer support in any way it can. As we are all practicing social distancing in an effort to flatten the curve\, we are offering this free webinar\, sponsored by Novateur Ventures for companies who are looking for a way to fast-track the approval process for their products. \nConfirmed Speakers: \n\nThomas Digby – Global IP Lead – Novateur Ventures\nIan McGill – Lead US Diagnostics Regulatory Affairs – Novateur Ventures\n\n\n\nFor more information\, please contact: \nRyan Butt \nSenior Manager\, Events & Outreach \nPhone: (604) 669-9909 ext. 104 \nEmail: rbutt@lifesciencesbc.ca
URL:https://scienceinvancouver.com/event/how-to-navigate-fast-track-approval-during-covid-19/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/04/How-to-Navigate-Fast-Track-Approval-during-COVID-19.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200421T130000
DTEND;TZID=America/Vancouver:20200421T140000
DTSTAMP:20260409T002838
CREATED:20200415T154430Z
LAST-MODIFIED:20200415T154430Z
UID:26135-1587474000-1587477600@scienceinvancouver.com
SUMMARY:How to Navigate Fast Track Approval during COVID-19
DESCRIPTION:During these times of uncertainty\, LifeSciences BC hopes to offer support in any way it can. This webinar is free for everyone.\n\n\n\n\n\n\nAbout this Event\n\n\nDuring these times of uncertainty\, LifeSciences BC hopes to offer support in any way it can. As we are all practicing social distancing in an effort to flatten the curve\, we are offering this free webinar\, sponsored by Novateur Ventures for companies who are looking for a way to fast-track the approval process for their products. \nConfirmed Speakers: \n\nThomas Digby – Global IP Lead – Novateur Ventures\nIan McGill – Lead US Diagnostics Regulatory Affairs – Novateur Ventures\n\n\n\nFor more information\, please contact: \nRyan Butt \nSenior Manager\, Events & Outreach \nPhone: (604) 669-9909 ext. 104 \nEmail: rbutt@lifesciencesbc.ca
URL:https://scienceinvancouver.com/event/how-to-navigate-fast-track-approval-during-covid-19-2/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/04/How-to-Navigate-Fast-Track-Approval-during-COVID-19.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200421T130000
DTEND;TZID=America/Vancouver:20200421T140000
DTSTAMP:20260409T002838
CREATED:20200415T154430Z
LAST-MODIFIED:20200415T154430Z
UID:27750-1587474000-1587477600@scienceinvancouver.com
SUMMARY:How to Navigate Fast Track Approval during COVID-19
DESCRIPTION:During these times of uncertainty\, LifeSciences BC hopes to offer support in any way it can. This webinar is free for everyone.\n\n\n\n\n\n\nAbout this Event\n\n\nDuring these times of uncertainty\, LifeSciences BC hopes to offer support in any way it can. As we are all practicing social distancing in an effort to flatten the curve\, we are offering this free webinar\, sponsored by Novateur Ventures for companies who are looking for a way to fast-track the approval process for their products. \nConfirmed Speakers: \n\nThomas Digby – Global IP Lead – Novateur Ventures\nIan McGill – Lead US Diagnostics Regulatory Affairs – Novateur Ventures\n\n\n\nFor more information\, please contact: \nRyan Butt \nSenior Manager\, Events & Outreach \nPhone: (604) 669-9909 ext. 104 \nEmail: rbutt@lifesciencesbc.ca
URL:https://scienceinvancouver.com/event/how-to-navigate-fast-track-approval-during-covid-19-3/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/04/How-to-Navigate-Fast-Track-Approval-during-COVID-19.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200421T130000
DTEND;TZID=America/Vancouver:20200421T140000
DTSTAMP:20260409T002838
CREATED:20200415T154430Z
LAST-MODIFIED:20200415T154430Z
UID:30833-1587474000-1587477600@scienceinvancouver.com
SUMMARY:How to Navigate Fast Track Approval during COVID-19
DESCRIPTION:During these times of uncertainty\, LifeSciences BC hopes to offer support in any way it can. This webinar is free for everyone.\n\n\n\n\n\n\nAbout this Event\n\n\nDuring these times of uncertainty\, LifeSciences BC hopes to offer support in any way it can. As we are all practicing social distancing in an effort to flatten the curve\, we are offering this free webinar\, sponsored by Novateur Ventures for companies who are looking for a way to fast-track the approval process for their products. \nConfirmed Speakers: \n\nThomas Digby – Global IP Lead – Novateur Ventures\nIan McGill – Lead US Diagnostics Regulatory Affairs – Novateur Ventures\n\n\n\nFor more information\, please contact: \nRyan Butt \nSenior Manager\, Events & Outreach \nPhone: (604) 669-9909 ext. 104 \nEmail: rbutt@lifesciencesbc.ca
URL:https://scienceinvancouver.com/event/how-to-navigate-fast-track-approval-during-covid-19-4/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/04/How-to-Navigate-Fast-Track-Approval-during-COVID-19.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200421T130000
DTEND;TZID=America/Vancouver:20200421T140000
DTSTAMP:20260409T002838
CREATED:20200415T154430Z
LAST-MODIFIED:20200415T154430Z
UID:32293-1587474000-1587477600@scienceinvancouver.com
SUMMARY:How to Navigate Fast Track Approval during COVID-19
DESCRIPTION:During these times of uncertainty\, LifeSciences BC hopes to offer support in any way it can. This webinar is free for everyone.\n\n\n\n\n\n\nAbout this Event\n\n\nDuring these times of uncertainty\, LifeSciences BC hopes to offer support in any way it can. As we are all practicing social distancing in an effort to flatten the curve\, we are offering this free webinar\, sponsored by Novateur Ventures for companies who are looking for a way to fast-track the approval process for their products. \nConfirmed Speakers: \n\nThomas Digby – Global IP Lead – Novateur Ventures\nIan McGill – Lead US Diagnostics Regulatory Affairs – Novateur Ventures\n\n\n\nFor more information\, please contact: \nRyan Butt \nSenior Manager\, Events & Outreach \nPhone: (604) 669-9909 ext. 104 \nEmail: rbutt@lifesciencesbc.ca
URL:https://scienceinvancouver.com/event/how-to-navigate-fast-track-approval-during-covid-19-5/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/04/How-to-Navigate-Fast-Track-Approval-during-COVID-19.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200422T080000
DTEND;TZID=America/Vancouver:20200425T170000
DTSTAMP:20260409T002838
CREATED:20200413T220525Z
LAST-MODIFIED:20200413T220525Z
UID:11070-1587542400-1587834000@scienceinvancouver.com
SUMMARY:The Allied Genetics Conference (TAGC) Online
DESCRIPTION:TAGC is a unique conference organized by the Genetics Society of America that fosters collaboration by alternating community-specific sessions with cross-community thematic sessions. After the in-person version of the meeting was canceled\, we recreated TAGC Online as a virtual meeting that allows you to share your research and stay connected without leaving your home. \nJoin us online April 22–25\, 2020. There is no cost to attend\, but you must register in advance! \nAt TAGC Online you can join colleagues from the C. elegans\,  Drosophila\, mammalian\, Xenopus\, yeast\, zebrafish\, and population\, evolutionary\, and quantitative genetics (PEQG) research communities—along with other researchers studying humans\, plants\, and agricultural species. In addition to the Community Sessions\, Thematic Sessions bring the communities together around unifying themes. \nOn April 22–25\, both Community and Thematic Sessions will be presented live online. TAGC 2020 Online will also include posters and inspiring Keynote Speakers\, followed by a program of poster discussion sessions and two-hour workshops in the weeks after the main event. TAGC 2020 is organized by dedicated members of the GSA community. We hope you’ll join us for this exciting experiment!
URL:https://scienceinvancouver.com/event/the-allied-genetics-conference-tagc-online/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200422T080000
DTEND;TZID=America/Vancouver:20200425T170000
DTSTAMP:20260409T002838
CREATED:20200413T220525Z
LAST-MODIFIED:20200413T220525Z
UID:26133-1587542400-1587834000@scienceinvancouver.com
SUMMARY:The Allied Genetics Conference (TAGC) Online
DESCRIPTION:TAGC is a unique conference organized by the Genetics Society of America that fosters collaboration by alternating community-specific sessions with cross-community thematic sessions. After the in-person version of the meeting was canceled\, we recreated TAGC Online as a virtual meeting that allows you to share your research and stay connected without leaving your home. \nJoin us online April 22–25\, 2020. There is no cost to attend\, but you must register in advance! \nAt TAGC Online you can join colleagues from the C. elegans\,  Drosophila\, mammalian\, Xenopus\, yeast\, zebrafish\, and population\, evolutionary\, and quantitative genetics (PEQG) research communities—along with other researchers studying humans\, plants\, and agricultural species. In addition to the Community Sessions\, Thematic Sessions bring the communities together around unifying themes. \nOn April 22–25\, both Community and Thematic Sessions will be presented live online. TAGC 2020 Online will also include posters and inspiring Keynote Speakers\, followed by a program of poster discussion sessions and two-hour workshops in the weeks after the main event. TAGC 2020 is organized by dedicated members of the GSA community. We hope you’ll join us for this exciting experiment!
URL:https://scienceinvancouver.com/event/the-allied-genetics-conference-tagc-online-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200422T080000
DTEND;TZID=America/Vancouver:20200425T170000
DTSTAMP:20260409T002838
CREATED:20200413T220525Z
LAST-MODIFIED:20200413T220525Z
UID:27748-1587542400-1587834000@scienceinvancouver.com
SUMMARY:The Allied Genetics Conference (TAGC) Online
DESCRIPTION:TAGC is a unique conference organized by the Genetics Society of America that fosters collaboration by alternating community-specific sessions with cross-community thematic sessions. After the in-person version of the meeting was canceled\, we recreated TAGC Online as a virtual meeting that allows you to share your research and stay connected without leaving your home. \nJoin us online April 22–25\, 2020. There is no cost to attend\, but you must register in advance! \nAt TAGC Online you can join colleagues from the C. elegans\,  Drosophila\, mammalian\, Xenopus\, yeast\, zebrafish\, and population\, evolutionary\, and quantitative genetics (PEQG) research communities—along with other researchers studying humans\, plants\, and agricultural species. In addition to the Community Sessions\, Thematic Sessions bring the communities together around unifying themes. \nOn April 22–25\, both Community and Thematic Sessions will be presented live online. TAGC 2020 Online will also include posters and inspiring Keynote Speakers\, followed by a program of poster discussion sessions and two-hour workshops in the weeks after the main event. TAGC 2020 is organized by dedicated members of the GSA community. We hope you’ll join us for this exciting experiment!
URL:https://scienceinvancouver.com/event/the-allied-genetics-conference-tagc-online-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200422T080000
DTEND;TZID=America/Vancouver:20200425T170000
DTSTAMP:20260409T002838
CREATED:20200413T220525Z
LAST-MODIFIED:20200413T220525Z
UID:30831-1587542400-1587834000@scienceinvancouver.com
SUMMARY:The Allied Genetics Conference (TAGC) Online
DESCRIPTION:TAGC is a unique conference organized by the Genetics Society of America that fosters collaboration by alternating community-specific sessions with cross-community thematic sessions. After the in-person version of the meeting was canceled\, we recreated TAGC Online as a virtual meeting that allows you to share your research and stay connected without leaving your home. \nJoin us online April 22–25\, 2020. There is no cost to attend\, but you must register in advance! \nAt TAGC Online you can join colleagues from the C. elegans\,  Drosophila\, mammalian\, Xenopus\, yeast\, zebrafish\, and population\, evolutionary\, and quantitative genetics (PEQG) research communities—along with other researchers studying humans\, plants\, and agricultural species. In addition to the Community Sessions\, Thematic Sessions bring the communities together around unifying themes. \nOn April 22–25\, both Community and Thematic Sessions will be presented live online. TAGC 2020 Online will also include posters and inspiring Keynote Speakers\, followed by a program of poster discussion sessions and two-hour workshops in the weeks after the main event. TAGC 2020 is organized by dedicated members of the GSA community. We hope you’ll join us for this exciting experiment!
URL:https://scienceinvancouver.com/event/the-allied-genetics-conference-tagc-online-4/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200422T080000
DTEND;TZID=America/Vancouver:20200425T170000
DTSTAMP:20260409T002838
CREATED:20200413T220525Z
LAST-MODIFIED:20200413T220525Z
UID:32291-1587542400-1587834000@scienceinvancouver.com
SUMMARY:The Allied Genetics Conference (TAGC) Online
DESCRIPTION:TAGC is a unique conference organized by the Genetics Society of America that fosters collaboration by alternating community-specific sessions with cross-community thematic sessions. After the in-person version of the meeting was canceled\, we recreated TAGC Online as a virtual meeting that allows you to share your research and stay connected without leaving your home. \nJoin us online April 22–25\, 2020. There is no cost to attend\, but you must register in advance! \nAt TAGC Online you can join colleagues from the C. elegans\,  Drosophila\, mammalian\, Xenopus\, yeast\, zebrafish\, and population\, evolutionary\, and quantitative genetics (PEQG) research communities—along with other researchers studying humans\, plants\, and agricultural species. In addition to the Community Sessions\, Thematic Sessions bring the communities together around unifying themes. \nOn April 22–25\, both Community and Thematic Sessions will be presented live online. TAGC 2020 Online will also include posters and inspiring Keynote Speakers\, followed by a program of poster discussion sessions and two-hour workshops in the weeks after the main event. TAGC 2020 is organized by dedicated members of the GSA community. We hope you’ll join us for this exciting experiment!
URL:https://scienceinvancouver.com/event/the-allied-genetics-conference-tagc-online-5/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200422T090000
DTEND;TZID=America/Vancouver:20200422T110000
DTSTAMP:20260409T002838
CREATED:20200330T191136Z
LAST-MODIFIED:20200330T191136Z
UID:10885-1587546000-1587553200@scienceinvancouver.com
SUMMARY:Webinar: Every Cell Has Its Place - In Situ Sequencing of Tissue Samples at Single-Cell Resolution
DESCRIPTION:Single-cell RNA sequencing (scRNA-seq) has revolutionized the understanding of tissue complexity by dissecting transcriptomic heterogeneity and revealing previously unknown cell types and states. However\, scRNA-seq does not allow the visualization of spatial organization of single cells within the tissue. In order to overcome this limitation\, spatial gene expression profiling technologies have emerged that aim to localize molecularly defined cell types within the morphological context. In situ sequencing (ISS) can rapidly analyze and visualize the expression of hundreds of genes within morphologically intact tissue samples at single-cell resolution. ISS helps researchers to understand complex biological and pathological mechanisms and to localize and validate new drug targets. \nIn this webinar\, we will outline the benefits of ISS and showcase how it can complement spatial transcriptomics technology in the task of unraveling the role of amyloid-ß plaques in the neurogenerative process of Alzheimer’s disease. \nDuring this webinar\, the speakers will: \n\nIntroduce ISS technology and how it enables simultaneous spatial analysis of hundreds of genes in tissue samples at single-cell resolution\nShow how ISS has helped shed light on the role of amyloid-ß plaques in Alzheimer’s disease\nDiscuss applications and performance of ISS in other research areas\nAnswer your questions during the live broadcast.\n\nThis webinar will last for approximately 60 minutes.
URL:https://scienceinvancouver.com/event/webinar-every-cell-has-its-place-in-situ-sequencing-of-tissue-samples-at-single-cell-resolution/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/03/Every-cell-has-its-place-webinar.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200422T090000
DTEND;TZID=America/Vancouver:20200422T110000
DTSTAMP:20260409T002838
CREATED:20200330T191136Z
LAST-MODIFIED:20200330T191136Z
UID:26120-1587546000-1587553200@scienceinvancouver.com
SUMMARY:Webinar: Every Cell Has Its Place - In Situ Sequencing of Tissue Samples at Single-Cell Resolution
DESCRIPTION:Single-cell RNA sequencing (scRNA-seq) has revolutionized the understanding of tissue complexity by dissecting transcriptomic heterogeneity and revealing previously unknown cell types and states. However\, scRNA-seq does not allow the visualization of spatial organization of single cells within the tissue. In order to overcome this limitation\, spatial gene expression profiling technologies have emerged that aim to localize molecularly defined cell types within the morphological context. In situ sequencing (ISS) can rapidly analyze and visualize the expression of hundreds of genes within morphologically intact tissue samples at single-cell resolution. ISS helps researchers to understand complex biological and pathological mechanisms and to localize and validate new drug targets. \nIn this webinar\, we will outline the benefits of ISS and showcase how it can complement spatial transcriptomics technology in the task of unraveling the role of amyloid-ß plaques in the neurogenerative process of Alzheimer’s disease. \nDuring this webinar\, the speakers will: \n\nIntroduce ISS technology and how it enables simultaneous spatial analysis of hundreds of genes in tissue samples at single-cell resolution\nShow how ISS has helped shed light on the role of amyloid-ß plaques in Alzheimer’s disease\nDiscuss applications and performance of ISS in other research areas\nAnswer your questions during the live broadcast.\n\nThis webinar will last for approximately 60 minutes.
URL:https://scienceinvancouver.com/event/webinar-every-cell-has-its-place-in-situ-sequencing-of-tissue-samples-at-single-cell-resolution-2/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/03/Every-cell-has-its-place-webinar.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200422T090000
DTEND;TZID=America/Vancouver:20200422T110000
DTSTAMP:20260409T002838
CREATED:20200330T191136Z
LAST-MODIFIED:20200330T191136Z
UID:27737-1587546000-1587553200@scienceinvancouver.com
SUMMARY:Webinar: Every Cell Has Its Place - In Situ Sequencing of Tissue Samples at Single-Cell Resolution
DESCRIPTION:Single-cell RNA sequencing (scRNA-seq) has revolutionized the understanding of tissue complexity by dissecting transcriptomic heterogeneity and revealing previously unknown cell types and states. However\, scRNA-seq does not allow the visualization of spatial organization of single cells within the tissue. In order to overcome this limitation\, spatial gene expression profiling technologies have emerged that aim to localize molecularly defined cell types within the morphological context. In situ sequencing (ISS) can rapidly analyze and visualize the expression of hundreds of genes within morphologically intact tissue samples at single-cell resolution. ISS helps researchers to understand complex biological and pathological mechanisms and to localize and validate new drug targets. \nIn this webinar\, we will outline the benefits of ISS and showcase how it can complement spatial transcriptomics technology in the task of unraveling the role of amyloid-ß plaques in the neurogenerative process of Alzheimer’s disease. \nDuring this webinar\, the speakers will: \n\nIntroduce ISS technology and how it enables simultaneous spatial analysis of hundreds of genes in tissue samples at single-cell resolution\nShow how ISS has helped shed light on the role of amyloid-ß plaques in Alzheimer’s disease\nDiscuss applications and performance of ISS in other research areas\nAnswer your questions during the live broadcast.\n\nThis webinar will last for approximately 60 minutes.
URL:https://scienceinvancouver.com/event/webinar-every-cell-has-its-place-in-situ-sequencing-of-tissue-samples-at-single-cell-resolution-3/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/03/Every-cell-has-its-place-webinar.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200422T090000
DTEND;TZID=America/Vancouver:20200422T110000
DTSTAMP:20260409T002838
CREATED:20200330T191136Z
LAST-MODIFIED:20200330T191136Z
UID:30820-1587546000-1587553200@scienceinvancouver.com
SUMMARY:Webinar: Every Cell Has Its Place - In Situ Sequencing of Tissue Samples at Single-Cell Resolution
DESCRIPTION:Single-cell RNA sequencing (scRNA-seq) has revolutionized the understanding of tissue complexity by dissecting transcriptomic heterogeneity and revealing previously unknown cell types and states. However\, scRNA-seq does not allow the visualization of spatial organization of single cells within the tissue. In order to overcome this limitation\, spatial gene expression profiling technologies have emerged that aim to localize molecularly defined cell types within the morphological context. In situ sequencing (ISS) can rapidly analyze and visualize the expression of hundreds of genes within morphologically intact tissue samples at single-cell resolution. ISS helps researchers to understand complex biological and pathological mechanisms and to localize and validate new drug targets. \nIn this webinar\, we will outline the benefits of ISS and showcase how it can complement spatial transcriptomics technology in the task of unraveling the role of amyloid-ß plaques in the neurogenerative process of Alzheimer’s disease. \nDuring this webinar\, the speakers will: \n\nIntroduce ISS technology and how it enables simultaneous spatial analysis of hundreds of genes in tissue samples at single-cell resolution\nShow how ISS has helped shed light on the role of amyloid-ß plaques in Alzheimer’s disease\nDiscuss applications and performance of ISS in other research areas\nAnswer your questions during the live broadcast.\n\nThis webinar will last for approximately 60 minutes.
URL:https://scienceinvancouver.com/event/webinar-every-cell-has-its-place-in-situ-sequencing-of-tissue-samples-at-single-cell-resolution-4/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/03/Every-cell-has-its-place-webinar.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200422T090000
DTEND;TZID=America/Vancouver:20200422T110000
DTSTAMP:20260409T002838
CREATED:20200330T191136Z
LAST-MODIFIED:20200330T191136Z
UID:32280-1587546000-1587553200@scienceinvancouver.com
SUMMARY:Webinar: Every Cell Has Its Place - In Situ Sequencing of Tissue Samples at Single-Cell Resolution
DESCRIPTION:Single-cell RNA sequencing (scRNA-seq) has revolutionized the understanding of tissue complexity by dissecting transcriptomic heterogeneity and revealing previously unknown cell types and states. However\, scRNA-seq does not allow the visualization of spatial organization of single cells within the tissue. In order to overcome this limitation\, spatial gene expression profiling technologies have emerged that aim to localize molecularly defined cell types within the morphological context. In situ sequencing (ISS) can rapidly analyze and visualize the expression of hundreds of genes within morphologically intact tissue samples at single-cell resolution. ISS helps researchers to understand complex biological and pathological mechanisms and to localize and validate new drug targets. \nIn this webinar\, we will outline the benefits of ISS and showcase how it can complement spatial transcriptomics technology in the task of unraveling the role of amyloid-ß plaques in the neurogenerative process of Alzheimer’s disease. \nDuring this webinar\, the speakers will: \n\nIntroduce ISS technology and how it enables simultaneous spatial analysis of hundreds of genes in tissue samples at single-cell resolution\nShow how ISS has helped shed light on the role of amyloid-ß plaques in Alzheimer’s disease\nDiscuss applications and performance of ISS in other research areas\nAnswer your questions during the live broadcast.\n\nThis webinar will last for approximately 60 minutes.
URL:https://scienceinvancouver.com/event/webinar-every-cell-has-its-place-in-situ-sequencing-of-tissue-samples-at-single-cell-resolution-5/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/03/Every-cell-has-its-place-webinar.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200422T100000
DTEND;TZID=America/Vancouver:20200422T110000
DTSTAMP:20260409T002838
CREATED:20200414T204038Z
LAST-MODIFIED:20200414T204038Z
UID:11076-1587549600-1587553200@scienceinvancouver.com
SUMMARY:Stem Cells from the Sofa Speaker Series: Dr. Josef Penninger
DESCRIPTION:Soluble ACE2 as a rational therapy for COVID-19\nJoin Dr. Josef Martin Penninger\, Director of the Life Sciences Institute at the University of British Columbia\, as he shares details from his recently published study on the cell surface protein\, ACE2\, as the key receptor for the SARS-CoV-2 virus. Dr. Penninger\, an Austrian geneticist and the Canada 150 Research Chair in Functional Genetics\, will outline how a soluble ACE2 can significantly block early stages of COVID-19\, presenting a new therapeutic option.
URL:https://scienceinvancouver.com/event/stem-cells-from-the-sofa-speaker-series-dr-josef-penninger/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/04/Stem-Cells-from-the-Sofa.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200422T100000
DTEND;TZID=America/Vancouver:20200422T110000
DTSTAMP:20260409T002838
CREATED:20200414T204038Z
LAST-MODIFIED:20200414T204038Z
UID:26134-1587549600-1587553200@scienceinvancouver.com
SUMMARY:Stem Cells from the Sofa Speaker Series: Dr. Josef Penninger
DESCRIPTION:Soluble ACE2 as a rational therapy for COVID-19\nJoin Dr. Josef Martin Penninger\, Director of the Life Sciences Institute at the University of British Columbia\, as he shares details from his recently published study on the cell surface protein\, ACE2\, as the key receptor for the SARS-CoV-2 virus. Dr. Penninger\, an Austrian geneticist and the Canada 150 Research Chair in Functional Genetics\, will outline how a soluble ACE2 can significantly block early stages of COVID-19\, presenting a new therapeutic option.
URL:https://scienceinvancouver.com/event/stem-cells-from-the-sofa-speaker-series-dr-josef-penninger-2/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/04/Stem-Cells-from-the-Sofa.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200422T100000
DTEND;TZID=America/Vancouver:20200422T110000
DTSTAMP:20260409T002838
CREATED:20200414T204038Z
LAST-MODIFIED:20200414T204038Z
UID:27749-1587549600-1587553200@scienceinvancouver.com
SUMMARY:Stem Cells from the Sofa Speaker Series: Dr. Josef Penninger
DESCRIPTION:Soluble ACE2 as a rational therapy for COVID-19\nJoin Dr. Josef Martin Penninger\, Director of the Life Sciences Institute at the University of British Columbia\, as he shares details from his recently published study on the cell surface protein\, ACE2\, as the key receptor for the SARS-CoV-2 virus. Dr. Penninger\, an Austrian geneticist and the Canada 150 Research Chair in Functional Genetics\, will outline how a soluble ACE2 can significantly block early stages of COVID-19\, presenting a new therapeutic option.
URL:https://scienceinvancouver.com/event/stem-cells-from-the-sofa-speaker-series-dr-josef-penninger-3/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/04/Stem-Cells-from-the-Sofa.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200422T100000
DTEND;TZID=America/Vancouver:20200422T110000
DTSTAMP:20260409T002838
CREATED:20200414T204038Z
LAST-MODIFIED:20200414T204038Z
UID:30832-1587549600-1587553200@scienceinvancouver.com
SUMMARY:Stem Cells from the Sofa Speaker Series: Dr. Josef Penninger
DESCRIPTION:Soluble ACE2 as a rational therapy for COVID-19\nJoin Dr. Josef Martin Penninger\, Director of the Life Sciences Institute at the University of British Columbia\, as he shares details from his recently published study on the cell surface protein\, ACE2\, as the key receptor for the SARS-CoV-2 virus. Dr. Penninger\, an Austrian geneticist and the Canada 150 Research Chair in Functional Genetics\, will outline how a soluble ACE2 can significantly block early stages of COVID-19\, presenting a new therapeutic option.
URL:https://scienceinvancouver.com/event/stem-cells-from-the-sofa-speaker-series-dr-josef-penninger-4/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/04/Stem-Cells-from-the-Sofa.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200422T100000
DTEND;TZID=America/Vancouver:20200422T110000
DTSTAMP:20260409T002838
CREATED:20200414T204038Z
LAST-MODIFIED:20200414T204038Z
UID:32292-1587549600-1587553200@scienceinvancouver.com
SUMMARY:Stem Cells from the Sofa Speaker Series: Dr. Josef Penninger
DESCRIPTION:Soluble ACE2 as a rational therapy for COVID-19\nJoin Dr. Josef Martin Penninger\, Director of the Life Sciences Institute at the University of British Columbia\, as he shares details from his recently published study on the cell surface protein\, ACE2\, as the key receptor for the SARS-CoV-2 virus. Dr. Penninger\, an Austrian geneticist and the Canada 150 Research Chair in Functional Genetics\, will outline how a soluble ACE2 can significantly block early stages of COVID-19\, presenting a new therapeutic option.
URL:https://scienceinvancouver.com/event/stem-cells-from-the-sofa-speaker-series-dr-josef-penninger-5/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/04/Stem-Cells-from-the-Sofa.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200422T100000
DTEND;TZID=America/Vancouver:20200422T110000
DTSTAMP:20260409T002838
CREATED:20200415T170446Z
LAST-MODIFIED:20200415T182056Z
UID:11087-1587549600-1587553200@scienceinvancouver.com
SUMMARY:STAT Digital Event: Antiviral Treatments. What Are the Odds?
DESCRIPTION:The pandemic caused by the novel coronavirus has shut down countries around the world. One of society’s biggest hopes is that treatments or even vaccines can be developed. \nJoin STAT for a three-part digital event series covering the race for new medicines that will impact Covid-19. The audience will be joined by executives from companies leading the way in developing treatments\, who will come prepared to answer tough questions. They’ll discuss current findings\, clinical trials\, and efforts to expedite approvals as we face this global pandemic. \nThis series will take place on Zoom\, an interactive platform where attendees will be able to not only see the discussions live\, but also participate by asking questions during the event. Access to the event is free. Access to the Zoom platform is limited to the first 1\,000 attendees; any additional attendees will be able to watch the conversation in real-time via a live stream on STAT’s website. \nPart 2: Antiviral treatments. What are the odds? April 22\, 2020 at 1PM EST \n\nSponsor Introduction: Richard Moscicki\, M.D.\, chief medical officer and executive vice president of Science and Regulatory Advocacy\, PhRMA\nDiana Brainard\, senior vice president\, HIV and Emerging Viral Infections at Gilead Sciences\, Inc.\nMatt Herper\, senior writer\, medicine\, and editorial director of events\, STAT
URL:https://scienceinvancouver.com/event/stat-digital-event-series-antiviral-treatments-what-are-the-odds/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/04/STAT-Digital-Event-Series-Combating-Covid-19.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200422T100000
DTEND;TZID=America/Vancouver:20200422T110000
DTSTAMP:20260409T002838
CREATED:20200415T170446Z
LAST-MODIFIED:20200415T170446Z
UID:26137-1587549600-1587553200@scienceinvancouver.com
SUMMARY:STAT Digital Event: Antiviral Treatments. What Are the Odds?
DESCRIPTION:The pandemic caused by the novel coronavirus has shut down countries around the world. One of society’s biggest hopes is that treatments or even vaccines can be developed. \nJoin STAT for a three-part digital event series covering the race for new medicines that will impact Covid-19. The audience will be joined by executives from companies leading the way in developing treatments\, who will come prepared to answer tough questions. They’ll discuss current findings\, clinical trials\, and efforts to expedite approvals as we face this global pandemic. \nThis series will take place on Zoom\, an interactive platform where attendees will be able to not only see the discussions live\, but also participate by asking questions during the event. Access to the event is free. Access to the Zoom platform is limited to the first 1\,000 attendees; any additional attendees will be able to watch the conversation in real-time via a live stream on STAT’s website. \nPart 2: Antiviral treatments. What are the odds? April 22\, 2020 at 1PM EST \n\nSponsor Introduction: Richard Moscicki\, M.D.\, chief medical officer and executive vice president of Science and Regulatory Advocacy\, PhRMA\nDiana Brainard\, senior vice president\, HIV and Emerging Viral Infections at Gilead Sciences\, Inc.\nMatt Herper\, senior writer\, medicine\, and editorial director of events\, STAT
URL:https://scienceinvancouver.com/event/stat-digital-event-series-antiviral-treatments-what-are-the-odds-2/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/04/STAT-Digital-Event-Series-Combating-Covid-19.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200422T100000
DTEND;TZID=America/Vancouver:20200422T110000
DTSTAMP:20260409T002838
CREATED:20200415T170446Z
LAST-MODIFIED:20200415T170446Z
UID:27752-1587549600-1587553200@scienceinvancouver.com
SUMMARY:STAT Digital Event: Antiviral Treatments. What Are the Odds?
DESCRIPTION:The pandemic caused by the novel coronavirus has shut down countries around the world. One of society’s biggest hopes is that treatments or even vaccines can be developed. \nJoin STAT for a three-part digital event series covering the race for new medicines that will impact Covid-19. The audience will be joined by executives from companies leading the way in developing treatments\, who will come prepared to answer tough questions. They’ll discuss current findings\, clinical trials\, and efforts to expedite approvals as we face this global pandemic. \nThis series will take place on Zoom\, an interactive platform where attendees will be able to not only see the discussions live\, but also participate by asking questions during the event. Access to the event is free. Access to the Zoom platform is limited to the first 1\,000 attendees; any additional attendees will be able to watch the conversation in real-time via a live stream on STAT’s website. \nPart 2: Antiviral treatments. What are the odds? April 22\, 2020 at 1PM EST \n\nSponsor Introduction: Richard Moscicki\, M.D.\, chief medical officer and executive vice president of Science and Regulatory Advocacy\, PhRMA\nDiana Brainard\, senior vice president\, HIV and Emerging Viral Infections at Gilead Sciences\, Inc.\nMatt Herper\, senior writer\, medicine\, and editorial director of events\, STAT
URL:https://scienceinvancouver.com/event/stat-digital-event-series-antiviral-treatments-what-are-the-odds-3/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/04/STAT-Digital-Event-Series-Combating-Covid-19.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200422T100000
DTEND;TZID=America/Vancouver:20200422T110000
DTSTAMP:20260409T002838
CREATED:20200415T170446Z
LAST-MODIFIED:20200415T170446Z
UID:30835-1587549600-1587553200@scienceinvancouver.com
SUMMARY:STAT Digital Event: Antiviral Treatments. What Are the Odds?
DESCRIPTION:The pandemic caused by the novel coronavirus has shut down countries around the world. One of society’s biggest hopes is that treatments or even vaccines can be developed. \nJoin STAT for a three-part digital event series covering the race for new medicines that will impact Covid-19. The audience will be joined by executives from companies leading the way in developing treatments\, who will come prepared to answer tough questions. They’ll discuss current findings\, clinical trials\, and efforts to expedite approvals as we face this global pandemic. \nThis series will take place on Zoom\, an interactive platform where attendees will be able to not only see the discussions live\, but also participate by asking questions during the event. Access to the event is free. Access to the Zoom platform is limited to the first 1\,000 attendees; any additional attendees will be able to watch the conversation in real-time via a live stream on STAT’s website. \nPart 2: Antiviral treatments. What are the odds? April 22\, 2020 at 1PM EST \n\nSponsor Introduction: Richard Moscicki\, M.D.\, chief medical officer and executive vice president of Science and Regulatory Advocacy\, PhRMA\nDiana Brainard\, senior vice president\, HIV and Emerging Viral Infections at Gilead Sciences\, Inc.\nMatt Herper\, senior writer\, medicine\, and editorial director of events\, STAT
URL:https://scienceinvancouver.com/event/stat-digital-event-series-antiviral-treatments-what-are-the-odds-4/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/04/STAT-Digital-Event-Series-Combating-Covid-19.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200422T100000
DTEND;TZID=America/Vancouver:20200422T110000
DTSTAMP:20260409T002838
CREATED:20200415T170446Z
LAST-MODIFIED:20200415T170446Z
UID:32295-1587549600-1587553200@scienceinvancouver.com
SUMMARY:STAT Digital Event: Antiviral Treatments. What Are the Odds?
DESCRIPTION:The pandemic caused by the novel coronavirus has shut down countries around the world. One of society’s biggest hopes is that treatments or even vaccines can be developed. \nJoin STAT for a three-part digital event series covering the race for new medicines that will impact Covid-19. The audience will be joined by executives from companies leading the way in developing treatments\, who will come prepared to answer tough questions. They’ll discuss current findings\, clinical trials\, and efforts to expedite approvals as we face this global pandemic. \nThis series will take place on Zoom\, an interactive platform where attendees will be able to not only see the discussions live\, but also participate by asking questions during the event. Access to the event is free. Access to the Zoom platform is limited to the first 1\,000 attendees; any additional attendees will be able to watch the conversation in real-time via a live stream on STAT’s website. \nPart 2: Antiviral treatments. What are the odds? April 22\, 2020 at 1PM EST \n\nSponsor Introduction: Richard Moscicki\, M.D.\, chief medical officer and executive vice president of Science and Regulatory Advocacy\, PhRMA\nDiana Brainard\, senior vice president\, HIV and Emerging Viral Infections at Gilead Sciences\, Inc.\nMatt Herper\, senior writer\, medicine\, and editorial director of events\, STAT
URL:https://scienceinvancouver.com/event/stat-digital-event-series-antiviral-treatments-what-are-the-odds-5/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2020/04/STAT-Digital-Event-Series-Combating-Covid-19.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200424T110000
DTEND;TZID=America/Vancouver:20200424T120000
DTSTAMP:20260409T002838
CREATED:20200422T221418Z
LAST-MODIFIED:20200422T221418Z
UID:11185-1587726000-1587729600@scienceinvancouver.com
SUMMARY:Zoom Talk: Methods and Tools for Interpreting Brain Transcriptomes
DESCRIPTION:Dr. Pavlidis will discuss concepts and challenges important to the use of RNA expression in neurogenomics and how they can be addressed using computational approaches. He will introduce some of the neuroinformatic resources his team has developed to help researchers benefit from this kind of data\, including Gemma (a curated database of over 10\,000 transcriptome studies) and NeuroExpresso (cell-type-specific expression patterns). One specific challenge in analyzing samples taken from brain tissue is cellular heterogeneity. Dr. Pavlidis will describe how this can be addressed to extract additional biological information from the data\, and an application to the study of schizophrenia and biopolar disorder \nTo join this talk\, click on the Zoom link here. The meeting ID is 624 107 423. If you want to call in\, you can find your local number here.
URL:https://scienceinvancouver.com/event/zoom-talk-methods-and-tools-for-interpreting-brain-transcriptomes/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200424T110000
DTEND;TZID=America/Vancouver:20200424T120000
DTSTAMP:20260409T002838
CREATED:20200422T221418Z
LAST-MODIFIED:20200422T221418Z
UID:26152-1587726000-1587729600@scienceinvancouver.com
SUMMARY:Zoom Talk: Methods and Tools for Interpreting Brain Transcriptomes
DESCRIPTION:Dr. Pavlidis will discuss concepts and challenges important to the use of RNA expression in neurogenomics and how they can be addressed using computational approaches. He will introduce some of the neuroinformatic resources his team has developed to help researchers benefit from this kind of data\, including Gemma (a curated database of over 10\,000 transcriptome studies) and NeuroExpresso (cell-type-specific expression patterns). One specific challenge in analyzing samples taken from brain tissue is cellular heterogeneity. Dr. Pavlidis will describe how this can be addressed to extract additional biological information from the data\, and an application to the study of schizophrenia and biopolar disorder \nTo join this talk\, click on the Zoom link here. The meeting ID is 624 107 423. If you want to call in\, you can find your local number here.
URL:https://scienceinvancouver.com/event/zoom-talk-methods-and-tools-for-interpreting-brain-transcriptomes-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200424T110000
DTEND;TZID=America/Vancouver:20200424T120000
DTSTAMP:20260409T002838
CREATED:20200422T221418Z
LAST-MODIFIED:20200422T221418Z
UID:27767-1587726000-1587729600@scienceinvancouver.com
SUMMARY:Zoom Talk: Methods and Tools for Interpreting Brain Transcriptomes
DESCRIPTION:Dr. Pavlidis will discuss concepts and challenges important to the use of RNA expression in neurogenomics and how they can be addressed using computational approaches. He will introduce some of the neuroinformatic resources his team has developed to help researchers benefit from this kind of data\, including Gemma (a curated database of over 10\,000 transcriptome studies) and NeuroExpresso (cell-type-specific expression patterns). One specific challenge in analyzing samples taken from brain tissue is cellular heterogeneity. Dr. Pavlidis will describe how this can be addressed to extract additional biological information from the data\, and an application to the study of schizophrenia and biopolar disorder \nTo join this talk\, click on the Zoom link here. The meeting ID is 624 107 423. If you want to call in\, you can find your local number here.
URL:https://scienceinvancouver.com/event/zoom-talk-methods-and-tools-for-interpreting-brain-transcriptomes-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200424T110000
DTEND;TZID=America/Vancouver:20200424T120000
DTSTAMP:20260409T002838
CREATED:20200422T221418Z
LAST-MODIFIED:20200422T221418Z
UID:30850-1587726000-1587729600@scienceinvancouver.com
SUMMARY:Zoom Talk: Methods and Tools for Interpreting Brain Transcriptomes
DESCRIPTION:Dr. Pavlidis will discuss concepts and challenges important to the use of RNA expression in neurogenomics and how they can be addressed using computational approaches. He will introduce some of the neuroinformatic resources his team has developed to help researchers benefit from this kind of data\, including Gemma (a curated database of over 10\,000 transcriptome studies) and NeuroExpresso (cell-type-specific expression patterns). One specific challenge in analyzing samples taken from brain tissue is cellular heterogeneity. Dr. Pavlidis will describe how this can be addressed to extract additional biological information from the data\, and an application to the study of schizophrenia and biopolar disorder \nTo join this talk\, click on the Zoom link here. The meeting ID is 624 107 423. If you want to call in\, you can find your local number here.
URL:https://scienceinvancouver.com/event/zoom-talk-methods-and-tools-for-interpreting-brain-transcriptomes-4/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200424T110000
DTEND;TZID=America/Vancouver:20200424T120000
DTSTAMP:20260409T002838
CREATED:20200422T221418Z
LAST-MODIFIED:20200422T221418Z
UID:32310-1587726000-1587729600@scienceinvancouver.com
SUMMARY:Zoom Talk: Methods and Tools for Interpreting Brain Transcriptomes
DESCRIPTION:Dr. Pavlidis will discuss concepts and challenges important to the use of RNA expression in neurogenomics and how they can be addressed using computational approaches. He will introduce some of the neuroinformatic resources his team has developed to help researchers benefit from this kind of data\, including Gemma (a curated database of over 10\,000 transcriptome studies) and NeuroExpresso (cell-type-specific expression patterns). One specific challenge in analyzing samples taken from brain tissue is cellular heterogeneity. Dr. Pavlidis will describe how this can be addressed to extract additional biological information from the data\, and an application to the study of schizophrenia and biopolar disorder \nTo join this talk\, click on the Zoom link here. The meeting ID is 624 107 423. If you want to call in\, you can find your local number here.
URL:https://scienceinvancouver.com/event/zoom-talk-methods-and-tools-for-interpreting-brain-transcriptomes-5/
LOCATION:Online
END:VEVENT
END:VCALENDAR